Menu Search
Equities

Chaoju Eye Care Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2219:HKG.HS

Chaoju Eye Care Holdings Ltd

Actions
  • Price (HKD)2.73
  • Today's Change-0.02 / -0.73%
  • Shares traded16.50k
  • 1 Year change-12.50%
  • Beta0.9551
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Chaoju Eye Care Holdings Ltd is an investment holding company principally engaged in the provision of in-patient services, out-patient services, sales of optical products and sales of equipment and medical consumables. The Company operates in three segments. The Consumer Ophthalmic Services segment is primarily engaged in the treatment and prevention of various types of ophthalmic disorders, including refractive correction, myopia prevention and control, dry eye syndrome, oculoplastic, as well as the provision of optical products and services. The Basic Ophthalmic Services segment is primarily engaged in the treatments of various common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases and pediatric eye diseases. The Company also operates Sales of Equipment and Medical Consumables segment. The Company primarily operates its businesses in the domestic market.

  • Revenue in HKD (TTM)1.55bn
  • Net income in HKD194.89m
  • Incorporated2020
  • Employees2.63k
  • Location
    Chaoju Eye Care Holdings LtdBlock A, Shouke Building24/F, East Zone,No. 14 Yard, West3rd Ring South Road, Fengtai DistrictBEIJING ChinaCHN
  • Websitehttps://www.chaojueye.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.